| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |